Brandywine Global Investment Management, LLC Astrazeneca PLC Transaction History

Brandywine Global Investment Management, LLC

$14.2 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$61.89 - $69.28 $1.77 Million - $1.98 Million	28,597 Added 8.16%	378,847 $25.5 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $7.15 Million - $7.91 Million	-110,273 Reduced 23.95%	350,250 $23.7 Million
Q2 2023 Aug 11, 2023	SELL	$69.91 - $75.81 $963,919 - $1.05 Million	-13,788 Reduced 2.91%	460,523 $33 Million
Q1 2023 May 12, 2023	SELL	$63.15 - $71.6 $1.44 Million - $1.63 Million	-22,768 Reduced 4.58%	474,311 $32.9 Million
Q4 2022 Feb 10, 2023	SELL	$54.21 - $70.44 $1.42 Million - $1.85 Million	-26,200 Reduced 5.01%	497,079 $33.7 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $455,229 - $1.17 Million	-8,586 Reduced 1.61%	523,279 $28.7 Million
Q2 2022 Aug 11, 2022	SELL	$59.26 - $71.14 $1.92 Million - $2.3 Million	-32,361 Reduced 5.74%	531,865 $35.1 Million
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $976,381 - $1.18 Million	-17,523 Reduced 3.01%	564,226 $37.4 Million
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $17.9 Million - $21.1 Million	-330,524 Reduced 36.23%	581,749 $33.9 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $24.4 Million - $26.7 Million	439,732 Added 93.06%	912,273 $54.8 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $2.28 Million - $2.83 Million	47,018 Added 11.05%	472,541 $28.3 Million
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $7.49 Million - $8.64 Million	158,759 Added 59.51%	425,523 $21.2 Million
Q4 2020 Feb 10, 2021	SELL	$48.52 - $58.02 $1.99 Million - $2.38 Million	-41,100 Reduced 13.35%	266,764 $13.3 Million
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $265,350 - $305,500	-5,000 Reduced 1.6%	307,864 $16.9 Million
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $6.74 Million - $8.65 Million	-156,350 Reduced 33.32%	312,864 $16.5 Million
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $18.7 Million - $25.4 Million	-495,250 Reduced 51.35%	469,214 $21 Million
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $1.38 Million - $1.63 Million	-32,400 Reduced 3.25%	964,464 $48.6 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $1.72 Million - $1.95 Million	-42,900 Reduced 4.13%	996,864 $44.4 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $38.8 Million - $43.3 Million	1,039,764 New	1,039,764 $42.9 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.

Account